
Enabling digital health, medical technologies, and care programs to secure economic validation.
Turn your technology’s early health‑economic case into a clear, evidence‑based story that inspires investors, payers, and clinical partners.
Demonstrate robust health‑economic evidence into a clear value that drives payer trust, reimbursement approval, and long‑term market strategy.
Empower your medtech projects with seamless collaboration, deep data access, and rapid, evidence‑driven results.
What We Offer
Early Economic & Value Demonstration
Using early economic insights and adoption evidence, we help you demonstrate how your solution delivers better care and reduces costs for patients and providers. This clear value story builds investor confidence and helps you connect earlier and more effectively with hospitals and clinics.
Robust Health Economic Modelling
Through advanced data-driven modelling, we demonstrate how your solution performs against current care using three key analyses: budget impact modelling, cost‑effectiveness analysis, and cost‑benefit assessment.
Generate the evidence needed for reimbursement and HTA acceptance.
Your Health Economics Capacity
Ad‑hoc health economics support that helps partners deliver faster, deeper, and more complete results. With access to clinical practices and economic data, including treatment costs and claims across Switzerland, the EU, and the US - with a trusted KOL network across multiple therapeutic areas.

Who We Are
Stepval is a health economics consulting boutique specializing in early-stage economic evaluation and health economic modeling for digital health solutions, medical devices, and personalized care programs.
Our differentiation lies in our therapeutic-area-specific service profiles, where internal domain experts engage at the earliest phase of client requests to deliver:
-
High-quality assessments aligned with payer and HTA requirements
-
Accelerated timelines through iterative model development
-
Efficiency gains via pre-validated analytic frameworks
Testimonials
"Stepval was great! Very responsive and quick without compromising quality"
A. Alnow, HTA director
Supported
by





















